Fargnoli MC - Search Results

1

Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma.

Peris K, Fargnoli MC, Chimenti S. Peris K, et al. Among authors: fargnoli mc. N Engl J Med. 1999 Dec 2;341(23):1767-8. doi: 10.1056/NEJM199912023412312. N Engl J Med. 1999. PMID: 10610445 No abstract available.

2

Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma.

Chimenti S, Peris K, Di Cristofaro S, Fargnoli MC, Torlone G. Chimenti S, et al. Among authors: fargnoli mc. Dermatology. 1995;190(3):214-7. doi: 10.1159/000246688. Dermatology. 1995. PMID: 7599384 Clinical Trial.

3

Multiple microsatellite alterations on chromosome 9 in neurofibromas of NF-1 patients.

Fargnoli MC, Chimenti S, Peris K. Fargnoli MC, et al. J Invest Dermatol. 1997 May;108(5):812-3. doi: 10.1111/1523-1747.ep12292279. J Invest Dermatol. 1997. PMID: 9129239 Free article. No abstract available.

4

Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk.

Fargnoli MC, Edelson RL, Berger CL, Chimenti S, Couture C, Mustelin T, Halaban R. Fargnoli MC, et al. Leukemia. 1997 Aug;11(8):1338-46. doi: 10.1038/sj.leu.2400745. Leukemia. 1997. PMID: 9264390

5

Peripheral nervous system involvement in a patient with large T-cell lymphoma arising from a pre-existing mycosis fungoides.

Peris K, Fargnoli MC, Berardelli A, Crecco M, Tomaselli R, Chimenti S. Peris K, et al. Among authors: fargnoli mc. Br J Dermatol. 1998 Aug;139(2):299-301. doi: 10.1046/j.1365-2133.1998.02371.x. Br J Dermatol. 1998. PMID: 9767248

6

CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds.

Fargnoli MC, Chimenti S, Keller G, Soyer HP, Dal Pozzo V, Höfler H, Peris K. Fargnoli MC, et al. J Invest Dermatol. 1998 Dec;111(6):1202-6. doi: 10.1046/j.1523-1747.1998.00412.x. J Invest Dermatol. 1998. PMID: 9856841 Free article.

7

UV fingerprint CDKN2a but no p14ARF mutations in sporadic melanomas.

Peris K, Chimenti S, Fargnoli MC, Valeri P, Kerl H, Wolf P. Peris K, et al. Among authors: fargnoli mc. J Invest Dermatol. 1999 May;112(5):825-6. doi: 10.1046/j.1523-1747.1999.00575.x. J Invest Dermatol. 1999. PMID: 10233780 Free article. No abstract available.

8

Reduced expression of CDKN2a/P16INK4a in mycosis fungoides.

Peris K, Stanta G, Fargnoli MC, Bonin S, Felli A, Amantea A, Chimenti S. Peris K, et al. Among authors: fargnoli mc. Arch Dermatol Res. 1999 Apr;291(4):207-11. doi: 10.1007/s004030050395. Arch Dermatol Res. 1999. PMID: 10335917

9

The use of chemical peelings in the treatment of different cutaneous hyperpigmentations.

Cotellessa C, Peris K, Onorati MT, Fargnoli MC, Chimenti S. Cotellessa C, et al. Among authors: fargnoli mc. Dermatol Surg. 1999 Jun;25(6):450-4. doi: 10.1046/j.1524-4725.1999.08217.x. Dermatol Surg. 1999. PMID: 10469091 Clinical Trial.

10

Mucosal involvement in a patient with lymphomatoid papulosis.

Chimenti S, Fargnoli MC, Pacifico A, Peris K. Chimenti S, et al. Among authors: fargnoli mc. J Am Acad Dermatol. 2001 Feb;44(2 Suppl):339-41. doi: 10.1067/mjd.2001.102669. J Am Acad Dermatol. 2001. PMID: 11174410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

320 results

Search Page

Filters